2022 Continuing Education Credits

Registrants are responsible for confirming that credits earned will be accepted for their specified certification by the appropriate accrediting body.

Attendance at conference events will be verified electronically. Each attendee seeking continuing education credits/hours will need to complete an evaluation for each session attended. Your login credentials will be used to track and tabulate each attendee’s continuing education credits/hours. After the conference, certificates documenting attendance and the number of continuing education credits/hours earned will be electronically generated and emailed to all eligible attendees. Questions concerning Continuing Education Credits may be directed to meetings@aatod.org.

To access your credits, click here.

CONTINUING EDUCATION HOURS OFFE RED For a complete listing of hours offered, click here.

2022 CONTINUING EDUCATION HOURS (CEH) CREDIT

ASWB-AATOD, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB), www.aswb.org, through the Approved Continuing Education (ACE) program. The American Association for the Treatment of Opioid Dependence (AATOD) maintains responsibility for the program. ASWB Approval Period: 6/12/2022-6/12/2025. Social workers should contact their regulatory board to determine course approval. Social workers participating in this course will receive up to 34.5 (clinical or social work ethics) continuing education clock hours. Please view the Conference Program for more information on specific learning outcomes and objectives, the target audience and the number of credit hours awarded for all conference sessions from ASWB. NAADAC-AATOD is an approved single event provider with

NAADAC, provider number 62794, offering credits for counselors. NAADAC provider status expires on January 31, 2024 for the AATOD 2022 Conference for up to 34.5 CE Credits.

ADACBGA – AATOD is an approved provider with the Alcohol & Drug Abuse Certification Board of Georgia (IC&RC Affiliate), provider number 2022-09-003, offering credits for counselors.

2022 CONTINUING NURSING EDUCATION (CNE) CREDIT NEMSD-This continuing nursing education activity was approved by the Northeast Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

NEMSD Approver Unit has Approved Continuing Nursing Education Activity, AATOD 2022 Conference for October 30- November 3, 2022, for 34.5 Contact Hours. 2022 CONTINUING MEDICAL EDUCATION (CME) CREDIT AMA Credit Designation Statement:
The American Society of Addiction Medicine designates this live activity for a maximum of 33.50 AMA PRA

Category 1 Credit (s) rM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Society of Addiction Medicine (ASAM) and the American Association for the Treatment of Opioid Dependence, Inc. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians. Disclosure Information
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. These policies include mitigating all relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CE Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

 

CME Committee Reviewer
Catharina Armstrong, MD, FASAM – No relevant financial disclosures
Cara A. Poland, MD, MEd, DFASAM – No relevant financial disclosures
R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM – No relevant financial disclosures
Herbert L. Malinoff, MD, FACP, DFASAM – No relevant financial disclosures
Noel llogu, MD, MRCP, FASAM – No relevant financial disclosures Presenters
Aaron Greenblatt, MD – No relevant financial disclosures
Adam Lewis, JD – No relevant financial disclosures
Aditi Ringwala, MD – No relevant financial disclosures
Alain Litwin, MD, MPH – No relevant financial disclosures
Alan Nolan, LCSW – No relevant financial disclosures
Allison Thomson, MPH – No relevant financial disclosures
Ally Lor, RN, CARN – No relevant financial disclosures
Andre Jean Remy, MD – No relevant financial disclosures
Andrea Walker, MA, MPH – No relevant financial disclosures
Andrew Schreier, ICS – No relevant financial disclosures
Andrew Stone, MD – No relevant financial disclosures
Andrew Talal, MD, MPH – No relevant financial disclosures
Anita Kennedy, BS CRPA CMA – No relevant financial disclosures
Anna Stewart, MBA- No relevant financial disclosures
Annabelle (Mimi) Belcher, PhD – No relevant financial disclosures
Anne Ruble, MD, MPH – No relevant financial disclosures
Anthony Folland, BA- No relevant financial disclosures
Arthur McFarlane, MS – No relevant financial disclosures
Ashton Marra, MS – No relevant financial disclosures
Babak lmanoel, DO- No relevant financial disclosures
Beth Rutkowski, MPH – No relevant financial disclosures
Brandee Izquierdo, DPA, MPA, CPRS – No relevant financial disclosures
Brenda Davis, MSW, CASAC-T, CMA – No relevant financial disclosures
Brian Myers, MBA, MTS, CMPE – No relevant financial disclosures
Brittania Liebla, DNP – No relevant financial disclosures
Carla Carter, JD – No relevant financial disclosures
Casey Tiefenwerth, MSW – No relevant financial disclosures
Catherine Abrams, LMSW, CAC-AD, RPS – No relevant financial disclosures Charissa Patricelli, MD – No relevant financial disclosures
Chrissie Martin, LMFT, LACS, CS – No relevant financial disclosures
Christina Mazza, RPS, CPRS, CCHW – No relevant financial disclosures Christine Neeb, MD – No relevant financial disclosures
Christine Scalise, MA, LPG, LCADC – No relevant financial disclosures Colleen Flanigan, RN, MS – No relevant financial disclosures
Dana Heilman, BS, MSW, MPH – No relevant financial disclosures
Daniel Barden, MS – No relevant financial disclosures
Darren McGregor, MS, MHS, LCMFT – No relevant financial disclosures David Whitesock – Does Disclose Commonly Well (Salary/Stockholder)
Deborah Reid, JD – No relevant financial disclosures
Deena Murphy, PhD – No relevant financial disclosures
Desmond Haneef – Perry, PRS – No relevant financial disclosures
Dona Dmitrovic, MHS – No relevant financial disclosures
Ed Soffe, LCSW-C – No relevant financial disclosures
Edward Long, AB, MA, PhD – No relevant financial disclosures
Elizabeth Connolly, MPA – No relevant financial disclosures
Ellen Weber, JD – No relevant financial disclosures
Emily Hosea – No relevant financial disclosures
Eric Schwartz, MD, MBA – No relevant financial disclosures
Eric Weintraub, MD – No relevant financial disclosures
Ericka Stropka, BS – No relevant financial disclosures
Faye Taxman, PhD – No relevant financial disclosures
Filippo Della Rocca – No relevant financial disclosures
Frances McGaffey, MPP – No relevant financial disclosures
G. Malik Burnett, MD, MBA, MPH – No relevant financial disclosures
Gabrielle de la Gueronniere, JD – No relevant financial disclosures
Gina Zaccagnino, LCSW – No relevant financial disclosures
Gregory Branch, MD, MBA, CPE – No relevant financial disclosures
Heather Raley, LCPC – No relevant financial disclosures
Hedi Levine, PhD – No relevant financial disclosures
Holly Hagle, PhD – No relevant financial disclosures
James Anderson, PA-C – No relevant financial disclosures
James Yoe, PhD – No relevant financial disclosures
Jason Kletter – Does Disclose BayMark Health Services (Employment) Salary
Jeffrey Hsu, MD – No relevant financial disclosures
Jessica Blose, LMHC, SUDP, NCC, CCMHC – No relevant financial disclosures John Brooklyn, MD – No relevant financial disclosures
John Hamilton, LMFT, LADC – No relevant financial disclosures
John McCarthy, MD – No relevant financial disclosures
Jonathan Stoltman, PhD – No relevant financial disclosures
Joshua Nirella, MS – No relevant financial relationships
Julie Achtyl, MS, LMHC, Master CASAC, NCC, ACS – No relevant financial disclosures Justin Berk, MD, MPH, MBA – No relevant financial disclosures
Kate Dunn, MSN, RN, CNL – No relevant financial disclosures
Katherine Findley, PhD, MSW – No relevant financial disclosures
Kathleen Rebbert-Franklin, LCSW-C – No relevant financial disclosures
Kathryn Cates-Wessel – No relevant financial disclosures
Katie Rouse, BA – No relevant financial disclosures
Kelly Coble, LCSW-C – No relevant financial disclosures
Kenneth Stoller – Does Disclose Berkshire Biomedical LLC (Consulting)
Kenny House, LCAS, CCS – No relevant financial disclosures
Kirsten Forseth, MPH – No relevant financial disclosures
Kisha Winston-Watkins, MBA, LCSW-C – No relevant financial disclosures
Kristi O’Malley, JD – No relevant financial disclosures
Krysten Garcia, BA – No relevant financial disclosures
Larry Onate, MD – No relevant financial disclosures
Latonya Adjei-Tabi, MPA – No relevant financial disclosures
Laura Maroldo – Does Disclose- AbbVie (Consulting) & Gilead (Speakers Bureau)
Laurie Krom, MS – No relevant financial disclosures
Linda Hurley, MA – No relevant financial disclosures
Lori Canane, LADC II – No relevant financial disclosures
Marc Fishman – Does Disclose Alkermes (Consulting) (Products/Services: Extended-release naltrexone) (Consulting Fees (e.g., advisory boards), research grant) Drug Delivery LLC (Consulting) (Products/Services: naltrexone implant) (Consulting Fees (e.g., advisory boards)
Margaret Marcello, BSN, RN, PMH-BC – No relevant financial disclosures
Maria Bruni, PhD – No relevant financial disclosures
Marian Currens, CRNP – No relevant financial disclosures
Marie Stratton, CHRS – No relevant financial disclosures
Mark Kraus, MD – No relevant financial disclosures
Mark Parrino, MPA – No relevant financial disclosures
Marla Oros, RN, MS, FAAN – No relevant financial disclosures
Mary Ann Thompson – No relevant financial disclosures
Mary Keller, MA – No relevant financial disclosures
Matthew Burgan, MD – No relevant financial disclosures
Maureen O’Neill Biggs, MSW, LCSW – No relevant financial disclosures
Meaghan Elliott, BS – No relevant financial disclosures
Megan Marx, MPA, NCPRSS – No relevant financial disclosures
Michael Gordon – Does Disclose Alkermes (Other Activities) (Products/Services: Study drug (VIVITROL) donation for NIDA/NIH study)
(Honoraria, Study drug) Braeburn (Other Activities) (Products/Services: study drug (BRIXADI/BUVADIL) for NIH/NIDA funded study) (Honoraria, Study drug) MedicaSafe (Other Activities) (Products/Services: Medication dispensing device for NIH/NIDA funded study) (Honoraria, medication dispensing device)
Michael Kidorf, PhD – No relevant financial disclosures
Michael Litterer, CHES, CPS, FHELA – No relevant financial disclosures
Michael Miller – Does Disclose US WorldMeds (Consulting) (Consulting Fees (e.g., advisory boards)
Michelle Byron, LPN – No relevant financial disclosures
Michelle Lalinde – No relevant financial disclosures
Michelle Marshall – No relevant financial disclosures
Miriam Delphin-Rittmon, PhD – No relevant financial disclosures
Mishka Terplan, MD – No relevant financial disclosures
Monica White, MS, CAC-AD, RPS – No relevant financial disclosures
Nancy Young, PhD – No relevant financial disclosures
Nicholas Van Dyke – Does Disclose BayMark Health Services (Employment)(Products/Services: Employee of company) (Salary) Nicole Augustine, MPH, MCHES, PS – No relevant financial disclosures
Patricia Precin, PhD – No relevant financial disclosures
Patti Juliana, PhD – No relevant financial disclosures
Rahul Gupta, MD, MPH, MBA, FACP – No relevant financial disclosures
Rebecca Trott, LCSW-C – No relevant financial disclosures
Rebekah Joab, JD – No relevant financial disclosures
Regina Gullette, PhD, LICDC-CS, MAC, SAP – No relevant financial disclosures
Robert Kent, JD – No relevant financial disclosures
Robin Rickard, JD – No relevant financial disclosures
Rosemarie Martin, PhD – No relevant financial disclosures
Ryan Mueller, MEd, LPC, LAC – No relevant financial disclosures
Sadie Smith, MSW – No relevant financial disclosures
Salima Montes, LCPC, CAC-AD – No relevant financial disclosures
Sara Gefvert, CRS/CPS, CMA – No relevant financial disclosures
Sarah Sweeney, MSW, MPH – No relevant financial disclosures
Shani Litwin, BA – No relevant financial disclosures
Sharif Nankoe, MD, MPA, MA, FASAM – No relevant financial disclosures
Sika Yeboah-Sampang, JD – No relevant financial disclosures
Steve Millette, MS – No relevant financial disclosures
Susan Hadley, MD – No relevant financial disclosures
Suzanne Borys, EdD – No relevant financial disclosures
Tara Kunkel, MSW – No relevant financial disclosures
Teri Morgan-Urie, CADCII – No relevant financial disclosures
Theresa Tassey, MD, MPH, MS – No relevant financial disclosures
Tina Masai – No relevant financial disclosures
Tracy Agee, NP – No relevant financial disclosures
Tracy Desruisseaux, LADC-1 – No relevant financial disclosures
Tracy Schulden, LCSW-C – No relevant financial disclosures
Tyrell Moyd, RPS, RCP- No relevant financial disclosures
Vanessa Baaklini, MSW – No relevant financial disclosures
Vickie Walters, LCSW-C – No relevant financial disclosures
Vinay Parekh, MD – No relevant financial disclosures
Yehoshua Mirkin – No relevant financial disclosures
Yngvild Olsen, MD, MPH – No relevant financial disclosures

Planning Committee
Kenneth Stoller, MD – Does disclose Berkshire Biomedical LLC (Consultant)
Susan A. Storti, PhD, RN, NEA-BC, CARN-AP – No relevant financial disclosures Holly Broce, MHA, LCADC – No relevant financial disclosures
Antoinette (Toni) Maynard-Carter – No relevant financial disclosures
Michael Rizzi – No relevant financial disclosures
Vickie L. Walters, LCSW-C – No relevant financial disclosures
Marian Currens CRNP Director – No relevant financial disclosures
Lillian Dannard, LCSW-C – No relevant financial disclosures
Robert C. Lambert, MA – No relevant financial disclosures
Barry Page – No relevant financial disclosures
Maria Ramos, CMP – No relevant financial disclosures
Brent Schwartz – No relevant financial disclosures
Tomell Harbison – No relevant financial disclosures
Mark W. Parrino, MPA – No relevant financial disclosures
Carleen Maxwell-Taylor – No relevant financial disclosures
Angelina Budija – No relevant financial disclosures
Sabrina Jones – No relevant financial disclosures

Visit the aatod conference website for more details…www.aatodconference.com.

@aatod1984
  • May 7, 2024 = #NationalFentanylAwarenessDay #JustSayKNOW
➡️ fentanylawarenessday.org

As many of you know, the #aatod2024 Conference is just one week away. Our impressive conference program consists of 2 Pre-Conference sessions, 4 Poster Author sessions and 1 Hot Topic Roundtable addressing the urgent problem of illicit fentanyl. These educational sessions are open to all conference attendees. 

Please visit our conference program for more details ➡️ bit.ly/3Ue57Q6
  • You won’t want to miss these 3 POWERFUL Plenary Sessions ready to set the stage in Las Vegas less than 2 weeks. Register today for the #aatod2024 Conference, the world's premier training conference event for the Treatment of Opioid Use Disorder ➡️www.aatodconference.com⬅️
  • 📣 Announcing the AMAZING Line-Up of Plenary Speakers

💻 View the #aatod2024 Conference Video Message from Ann Jamieson, MS,LADC/MH - AATOD’s Plenary Chair.

😊 We couldn’t be more excited about what we have in store for you next week in the spectacular city of Las Vegas where we will convene our conference!

🎤 You will not want to miss the three impressive plenary sessions that have been organized to deliver you extraordinary presentations for your educational purposes. These Plenary Sessions will cover a range of topics that highlight our conference theme, “Treating Opioid Use Disorder: So Much More Than Medication.” We have packed a lot of information into the plenary sessions and are excited to present the policies and strategies in Nevada and nationally.

Join us in Las Vegas by registering for the #aatod2024 Conference ➡️ www.aatodconference.com.
  • Register for the #aatod2024 Conference ➡️ www.aatodconference.com

⭐️ Conference Program Spotlight ⭐️
We know that opioid use disorder (OUD) knows no geographic boundaries. And, while there are countless initiatives, projects, policy reviews, opportunities, and challenges here in the United States, others around the world are facing and dealing with these same issues as well as successes that will be shared at the conference. 
 
Because we believe it is important and imperative to understand the good and essential work that is being done world-wide, Dr Maremmani and Mike Rizzi (AATOD International Chair) invite you to not only come to the conference but to join us at our Sunday (5/19) International Symposium. Respected international colleagues will address responses and findings related to treatment, recovery, and research in their countries. There will also be a special International Workshop on Tuesday, 5/21.
  • 🏆 Conference Workshop News 

💻 View the latest Conference Video Message from Robert Lambert, AATOD’s Workshop Chair 

The #aatod2024 conference is right around the corner and being held on May 18 – 22, 2024, at the Planet Hollywood Resort in Las Vegas, Nevada. It will be a great opportunity to meet with colleagues, share experiences and insights, learn about new innovative initiatives, and discuss emerging policy developments. 
 
We are pleased to present a dynamic workshop lineup that includes extremely rich and diverse educational content for all disciplines.  The workshop lineup will include state of the art information on diverse areas of focus such as patient care and best practices, building community partnerships, public policy and regulatory changes, workforce development, quality assurance, and financial reimbursement. There will be workshops that focus on emerging treatment trends and developments such as the fentanyl epidemic, mobile opioid treatment programs, expansion of treatment services in rural areas, integrating treatment with the corrections systems, and integrating harm reduction initiatives. 

View the comprehensive listing and descriptions of the conference sessions
➡ bit.ly/3Ue57Q6
  • CONGRATULATIONS to the #aatod2024 Award Recipients ➡️ https://conta.cc/4ccI9PI. 

🏆 The 2024 American Association for the Treatment of Opioid Dependence, Inc. (AATOD) Conference will be held in Las Vegas, NV where we will recognize the outstanding contributions to opioid treatment by honoring the 2024 award recipients. Please join us at the Awards Ceremony prior to the Middle Plenary Session the morning of Tuesday, May 21, 2024 to pay tribute and honor the individuals who have been nominated and selected by their peers for extraordinary service. 

💻 View the latest Conference Video Message from Sharel Downs, AATOD's Award Committee Chair 
➡️ https://youtu.be/hbsBIWP-QqE?si=9JQPLWbNBcPHog4_
  • The 2024 AATOD Conference is returning to the magnificent city of Las Vegas on May 18-22, 2024, at the Planet Hollywood Las Vegas Resort and Casino. We invite you to join us as we continue to address the opioid epidemic.

The conference theme, Treating Opioid Use Disorders: So Much More Than Medication, allows us to educate, collaborate and discuss the devastating impact of opioid use if untreated.

You don't want to miss the opportunity to attend world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024 #OUD #morethanmedicine

REGISTER ➡️ aatodconference.com
  • 💻 Greetings from the  #aatod2024 International Chair ➡️ bit.ly/3wjz5sf 👋 

“Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi
  • ✅ Final Reminder 

🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024

💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45

📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
  • Standard Registration Deadline:
TOMORROW - Tuesday, April 30, 2024

Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

Register ➡️ aatodconference.com
May 7, 2024 = #NationalFentanylAwarenessDay #JustSayKNOW
➡️ fentanylawarenessday.org

As many of you know, the #aatod2024 Conference is just one week away. Our impressive conference program consists of 2 Pre-Conference sessions, 4 Poster Author sessions and 1 Hot Topic Roundtable addressing the urgent problem of illicit fentanyl. These educational sessions are open to all conference attendees. 

Please visit our conference program for more details ➡️ bit.ly/3Ue57Q6
May 7, 2024 = #NationalFentanylAwarenessDay #JustSayKNOW ➡️ fentanylawarenessday.org As many of you know, the #aatod2024 Conference is just one week away. Our impressive conference program consists of 2 Pre-Conference sessions, 4 Poster Author sessions and 1 Hot Topic Roundtable addressing the urgent problem of illicit fentanyl. These educational sessions are open to all conference attendees. Please visit our conference program for more details ➡️ bit.ly/3Ue57Q6
4 days ago
View on Instagram |
1/10
You won’t want to miss these 3 POWERFUL Plenary Sessions ready to set the stage in Las Vegas less than 2 weeks. Register today for the #aatod2024 Conference, the world's premier training conference event for the Treatment of Opioid Use Disorder ➡️www.aatodconference.com⬅️
You won’t want to miss these 3 POWERFUL Plenary Sessions ready to set the stage in Las Vegas less than 2 weeks. Register today for the #aatod2024 Conference, the world's premier training conference event for the Treatment of Opioid Use Disorder ➡️www.aatodconference.com⬅️
You won’t want to miss these 3 POWERFUL Plenary Sessions ready to set the stage in Las Vegas less than 2 weeks. Register today for the #aatod2024 Conference, the world's premier training conference event for the Treatment of Opioid Use Disorder ➡️www.aatodconference.com⬅️
You won’t want to miss these 3 POWERFUL Plenary Sessions ready to set the stage in Las Vegas less than 2 weeks. Register today for the #aatod2024 Conference, the world's premier training conference event for the Treatment of Opioid Use Disorder ➡️www.aatodconference.com⬅️
6 days ago
View on Instagram |
2/10
📣 Announcing the AMAZING Line-Up of Plenary Speakers 💻 View the #aatod2024 Conference Video Message from Ann Jamieson, MS,LADC/MH - AATOD’s Plenary Chair. 😊 We couldn’t be more excited about what we have in store for you next week in the spectacular city of Las Vegas where we will convene our conference! 🎤 You will not want to miss the three impressive plenary sessions that have been organized to deliver you extraordinary presentations for your educational purposes. These Plenary Sessions will cover a range of topics that highlight our conference theme, “Treating Opioid Use Disorder: So Much More Than Medication.” We have packed a lot of information into the plenary sessions and are excited to present the policies and strategies in Nevada and nationally. Join us in Las Vegas by registering for the #aatod2024 Conference ➡️ www.aatodconference.com.
7 days ago
View on Instagram |
3/10
Register for the #aatod2024 Conference ➡️ www.aatodconference.com

⭐️ Conference Program Spotlight ⭐️
We know that opioid use disorder (OUD) knows no geographic boundaries. And, while there are countless initiatives, projects, policy reviews, opportunities, and challenges here in the United States, others around the world are facing and dealing with these same issues as well as successes that will be shared at the conference. 
 
Because we believe it is important and imperative to understand the good and essential work that is being done world-wide, Dr Maremmani and Mike Rizzi (AATOD International Chair) invite you to not only come to the conference but to join us at our Sunday (5/19) International Symposium. Respected international colleagues will address responses and findings related to treatment, recovery, and research in their countries. There will also be a special International Workshop on Tuesday, 5/21.
Register for the #aatod2024 Conference ➡️ www.aatodconference.com ⭐️ Conference Program Spotlight ⭐️ We know that opioid use disorder (OUD) knows no geographic boundaries. And, while there are countless initiatives, projects, policy reviews, opportunities, and challenges here in the United States, others around the world are facing and dealing with these same issues as well as successes that will be shared at the conference. Because we believe it is important and imperative to understand the good and essential work that is being done world-wide, Dr Maremmani and Mike Rizzi (AATOD International Chair) invite you to not only come to the conference but to join us at our Sunday (5/19) International Symposium. Respected international colleagues will address responses and findings related to treatment, recovery, and research in their countries. There will also be a special International Workshop on Tuesday, 5/21.
1 week ago
View on Instagram |
4/10
🏆 Conference Workshop News 💻 View the latest Conference Video Message from Robert Lambert, AATOD’s Workshop Chair The #aatod2024 conference is right around the corner and being held on May 18 – 22, 2024, at the Planet Hollywood Resort in Las Vegas, Nevada. It will be a great opportunity to meet with colleagues, share experiences and insights, learn about new innovative initiatives, and discuss emerging policy developments. We are pleased to present a dynamic workshop lineup that includes extremely rich and diverse educational content for all disciplines. The workshop lineup will include state of the art information on diverse areas of focus such as patient care and best practices, building community partnerships, public policy and regulatory changes, workforce development, quality assurance, and financial reimbursement. There will be workshops that focus on emerging treatment trends and developments such as the fentanyl epidemic, mobile opioid treatment programs, expansion of treatment services in rural areas, integrating treatment with the corrections systems, and integrating harm reduction initiatives. View the comprehensive listing and descriptions of the conference sessions ➡ bit.ly/3Ue57Q6
1 week ago
View on Instagram |
5/10
CONGRATULATIONS to the #aatod2024 Award Recipients ➡️ https://conta.cc/4ccI9PI. 

🏆 The 2024 American Association for the Treatment of Opioid Dependence, Inc. (AATOD) Conference will be held in Las Vegas, NV where we will recognize the outstanding contributions to opioid treatment by honoring the 2024 award recipients. Please join us at the Awards Ceremony prior to the Middle Plenary Session the morning of Tuesday, May 21, 2024 to pay tribute and honor the individuals who have been nominated and selected by their peers for extraordinary service. 

💻 View the latest Conference Video Message from Sharel Downs, AATOD's Award Committee Chair 
➡️ https://youtu.be/hbsBIWP-QqE?si=9JQPLWbNBcPHog4_
CONGRATULATIONS to the #aatod2024 Award Recipients ➡️ https://conta.cc/4ccI9PI. 🏆 The 2024 American Association for the Treatment of Opioid Dependence, Inc. (AATOD) Conference will be held in Las Vegas, NV where we will recognize the outstanding contributions to opioid treatment by honoring the 2024 award recipients. Please join us at the Awards Ceremony prior to the Middle Plenary Session the morning of Tuesday, May 21, 2024 to pay tribute and honor the individuals who have been nominated and selected by their peers for extraordinary service. 💻 View the latest Conference Video Message from Sharel Downs, AATOD's Award Committee Chair ➡️ https://youtu.be/hbsBIWP-QqE?si=9JQPLWbNBcPHog4_
2 weeks ago
View on Instagram |
6/10
The 2024 AATOD Conference is returning to the magnificent city of Las Vegas on May 18-22, 2024, at the Planet Hollywood Las Vegas Resort and Casino. We invite you to join us as we continue to address the opioid epidemic.

The conference theme, Treating Opioid Use Disorders: So Much More Than Medication, allows us to educate, collaborate and discuss the devastating impact of opioid use if untreated.

You don't want to miss the opportunity to attend world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024 #OUD #morethanmedicine

REGISTER ➡️ aatodconference.com
The 2024 AATOD Conference is returning to the magnificent city of Las Vegas on May 18-22, 2024, at the Planet Hollywood Las Vegas Resort and Casino. We invite you to join us as we continue to address the opioid epidemic. The conference theme, Treating Opioid Use Disorders: So Much More Than Medication, allows us to educate, collaborate and discuss the devastating impact of opioid use if untreated. You don't want to miss the opportunity to attend world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024 #OUD #morethanmedicine REGISTER ➡️ aatodconference.com
2 weeks ago
View on Instagram |
7/10
💻 Greetings from the  #aatod2024 International Chair ➡️ bit.ly/3wjz5sf 👋 

“Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi
💻 Greetings from the #aatod2024 International Chair ➡️ bit.ly/3wjz5sf 👋 “Buon giorno, bon jour, buenas dias, goedemorgen, boker tov, dobro utro, godan daginn, bom dia, dobro jutro, god morgon. Just a few ways to say good morning at AATOD Las Vegas. Our international colleagues are making their plans to attend, and now you have many ways to say hello. So, break out your Babel and Rosetta Stone and practice, practice, practice. A warm and friendly greeting is always welcome and a great conversation starter.” - Michael Rizzi
2 weeks ago
View on Instagram |
8/10
✅ Final Reminder 

🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024

💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45

📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
✅ Final Reminder 🏨 TODAY is the AATOD Room Block Reservation Deadline - Tuesday, April 30, 2024 💻 Book Your Stay for the #aatod2024 Conference ➡️ bit.ly/3wpsj45 📝 NOTE: The 2024 AATOD Conference will be held at the Planet Hollywood Resort and Casino but all sleeping rooms are soldout. Therefore, AATOD has secured an overflow block of rooms at a discounted rate allocated for AATOD conference attendees at the Paris Las Vegas Hotel and Casino, the OFFICIAL 2024 AATOD Conference Overflow Block. The negotiated rate includes a waived resort fee. These rates will be available, based on availability, until Tuesday, April 30, 2024. The government rate will not be offered within the AATOD block of rooms at the Paris Las Vegas Hotel and Casino.
2 weeks ago
View on Instagram |
9/10
Standard Registration Deadline:
TOMORROW - Tuesday, April 30, 2024

Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

Register ➡️ aatodconference.com
Standard Registration Deadline: TOMORROW - Tuesday, April 30, 2024 Don't miss out on the chance to attend the AATOD 2024 Conference, �the world's premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024 Register ➡️ aatodconference.com
2 weeks ago
View on Instagram |
10/10

#aatod2024 Conference – Las Vegas

COUNTDOWN

2024 Conference

AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram
Stay Connected to AATOD